Press Releases 2018

PsychoGenics Obtains License to the TgF344-AD Rat Model of Alzheimer’s Disease

March 15, 2018 – PARAMUS, N.J., – PsychoGenics Inc. (PGI) announced today that it obtained a license from the National Institute of Mental Health (NIMH), part of the National Institutes of Health, to the TgF344-AD rat model of Alzheimer’s disease (AD). This model expresses mutant human amyloid precursor protein (APPSW) and presenilin 1(PS1ΔE9) genes—each independent causes of early-onset familial AD.  Read More.


  • PsychoGenics
  • 215 College Road, Paramus, NJ 07652
  • Tel: (914) 406-8000
  • Fax: (914) 406-8090